New Insights Into Interatrial Shunting From the REDUCE-LAP II Study

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Both) - Corvia
• Consultant Fee/Honoraria/Speaker's Bureau (Both) - Eli Lilly
• Patient selection committee (Both) - Axon
• Events adjudication committee (Both) - CVRx